Abrdn PLC Dexcom Inc Transaction History

Abrdn PLC

$57.3 Billion
Q2 2025

A detailed history of Abrdn PLC transactions in Dexcom Inc stock. As of the latest transaction made, Abrdn PLC holds 305,430 shares of DXCM stock, worth $21.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

305,430

Previous 360,724 15.33%

Holding current value

$21.6 Million

Previous $24.6 Million 8.23%

% of portfolio

0.05%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$59.83 - $87.57 $3.31 Million - $4.84 Million	-55,294 Reduced 15.33%	305,430 $26.7 Million
Q1 2025 May 13, 2025	BUY	$67.74 - $90.75 $892,339 - $1.2 Million	13,173 Added 3.79%	360,724 $24.6 Million
Q4 2024 Jan 24, 2025	SELL	$65.68 - $81.01 $2.44 Million - $3.01 Million	-37,095 Reduced 9.64%	347,551 $27 Million
Q3 2024 Oct 24, 2024	BUY	$64.0 - $116.06 $5.45 Million - $9.89 Million	85,174 Added 28.44%	384,646 $25.8 Million
Q2 2024 Aug 09, 2024	SELL	$110.31 - $140.45 $10.4 Million - $13.2 Million	-94,153 Reduced 23.92%	299,472 $34 Million
Q1 2024 May 08, 2024	BUY	$114.22 - $140.1 $1.5 Million - $1.83 Million	13,090 Added 3.44%	393,625 $54.6 Million
Q4 2023 Jan 31, 2024	BUY	$75.49 - $124.16 $5.01 Million - $8.24 Million	66,348 Added 21.12%	380,535 $47.2 Million
Q3 2023 Nov 06, 2023	BUY	$86.06 - $137.93 $1.24 Million - $1.99 Million	14,401 Added 4.8%	314,187 $29.3 Million
Q2 2023 Jun 20, 2024	BUY	$112.47 - $130.98 $3 Million - $3.49 Million	26,646 Added 9.76%	299,786 $38.5 Million
Q2 2023 Aug 04, 2023	BUY	$112.47 - $130.98 $3 Million - $3.49 Million	26,646 Added 9.76%	299,786 $38.5 Million
Q1 2023 Jun 20, 2024	BUY	$104.0 - $122.92 $2.14 Million - $2.53 Million	20,615 Added 8.16%	273,140 $31.7 Million
Q1 2023 Apr 28, 2023	BUY	$104.0 - $122.92 $2.14 Million - $2.53 Million	20,615 Added 8.16%	273,140 $31.7 Million
Q4 2022 Jun 20, 2024	SELL	$84.98 - $122.67 $12 Million - $17.3 Million	-141,100 Reduced 35.85%	252,525 $28.6 Million
Q4 2022 Feb 09, 2023	BUY	$84.98 - $122.67 $1.53 Million - $2.21 Million	18,018 Added 7.68%	252,525 $28.6 Million
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $7.25 Million - $8.95 Million	95,001 Added 68.1%	234,507 $18.9 Million
Q2 2022 Aug 05, 2022	BUY	$67.99 - $132.89 $7.34 Million - $14.3 Million	107,968 Added 342.34%	139,506 $10.5 Million
Q1 2022 May 04, 2022	SELL	$94.08 - $130.2 $113,272 - $156,760	-1,204 Reduced 3.68%	31,538 $16.3 Million
Q4 2021 Feb 08, 2022	SELL	$129.87 - $162.82 $211,947 - $265,722	-1,632 Reduced 4.75%	32,742 $17.6 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $160,918 - $215,915	1,508 Added 4.59%	34,374 $18.7 Million
Q2 2021 Aug 10, 2021	SELL	$80.99 - $107.93 $66,735 - $88,934	-824 Reduced 2.45%	32,866 $14 Million
Q1 2021 May 06, 2021	BUY	$84.79 - $104.74 $162,288 - $200,472	1,914 Added 6.02%	33,690 $12.1 Million
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $202,800 - $271,700	2,600 Added 8.91%	31,776 $11.8 Million
Q3 2020 Oct 21, 2020	SELL	$95.51 - $112.95 $369,528 - $437,003	-3,869 Reduced 11.71%	29,176 $12 Million
Q2 2020 Aug 10, 2020	BUY	$62.68 - $105.34 $1.29 Million - $2.17 Million	20,615 Added 165.85%	33,045 $13.4 Million
Q1 2020 May 13, 2020	BUY	$47.79 - $75.63 $11,326 - $17,924	237 Added 1.94%	12,430 $3.35 Million
Q4 2019 Feb 18, 2020	BUY	$36.62 - $57.29 $4,577 - $7,161	125 Added 1.04%	12,193 $2.67 Million
Q3 2019 Nov 13, 2019	BUY	$35.53 - $43.8 $18,937 - $23,345	533 Added 4.62%	12,068 $1.8 Million
Q2 2019 Aug 13, 2019	BUY	$27.84 - $38.92 $6,347 - $8,873	228 Added 2.02%	11,535 $1.73 Million
Q1 2019 May 14, 2019	BUY	$28.07 - $38.18 $186,777 - $254,049	6,654 Added 143.0%	11,307 $1.35 Million
Q4 2018 Feb 12, 2019	BUY	$26.99 - $37.37 $125,584 - $173,882	4,653 New	4,653 $549,000

Others Institutions Holding DXCM

# of Institutions

1,107

Shares Held

370M

Call Options Held

5.32M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $27.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account